LaQuinta Jernigan

LaQuinta Jernigan is Chief Commercial Officer at mdgroup, where she leads global commercial strategy and partnerships for patient-first clinical trial solutions. With extensive experience across the life sciences sector, LaQuinta brings a strong track record of building sustainable, high-impact partnerships that support sponsors and CROs in delivering more effective, patient-centered studies.
 
Her background spans both commercial and operational roles, giving her a well-rounded perspective on the complexities of modern clinical trials. She works closely with clients to understand their strategic goals and operational challenges, helping design tailored solutions that improve patient engagement, streamline delivery, and drive successful outcomes. LaQuinta is particularly focused on balancing speed, quality, and cost—ensuring studies remain efficient while keeping patient needs at the forefront.

Passionate about advancing the clinical trial experience, LaQuinta champions approaches that reduce barriers to participation and improve accessibility for diverse patient populations. She is a strong advocate for integrating personalized support services, digital innovation, and flexible trial models to better align research with real-world patient lives.
 
At mdgroup, LaQuinta is dedicated to strengthening collaboration across the clinical ecosystem—bringing together sponsors, CROs, healthcare providers, and patient communities to create more inclusive and effective research. She believes that meaningful progress in clinical trials comes from combining operational excellence with empathy, ensuring every patient is treated not just as a participant, but as a person at the center of the journey.